Literature DB >> 20417630

Plasma concentrations of Gas6 and soluble Axl correlate with disease and predict mortality in patients with critical limb ischemia.

Carl Ekman1, Anders Gottsäter, Bengt Lindblad, Björn Dahlbäck.   

Abstract

INTRODUCTION: Critical limb ischemia (CLI) is a severe peripheral arterial disease, characterized by rest pain, ulcers and gangrene in the legs. Gas6 is a vitamin K-dependent protein, which binds and activates the tyrosine kinase receptor Axl. Gas6-mediated Axl-signaling influences endothelial activation, neointima formation and immune regulation. Axl can be cleaved and soluble Axl (sAxl) is detectable in circulation. DESIGN AND METHODS: We quantified plasma concentrations of Gas6 and sAxl in 189 CLI patients and 204 controls.
RESULTS: Gas6 and sAxl concentrations were increased in the CLI patients (p<0.0001) and correlated to C-reactive protein, interleukin-6, tumor necrosis factor alpha and neopterin. Patients who died within 3years of sampling (n=84) had increased concentrations of Gas6 and sAxl as compared to survivors (p=0.0009 and p=0.0011).
CONCLUSIONS: Plasma concentrations of Gas6 and sAxl correlate to inflammation and predict survival. This indicates that Gas6 and sAxl have a role in CLI, presumably connected to the inflammatory process. Copyright 2010 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20417630     DOI: 10.1016/j.clinbiochem.2010.04.006

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  14 in total

1.  Plasma growth arrest-specific protein 6 levels in premenopausal and postmenopausal women: the role of endogenous estrogen.

Authors:  Yi-Jen Hung; Chien-Hsing Lee; Yi-Shing Shieh; Fone-Ching Hsiao; Fu-Huang Lin; Chang-Hsun Hsieh
Journal:  Endocrine       Date:  2014-03-28       Impact factor: 3.633

2.  Growth arrest-specific gene 6 (Gas6) levels are elevated in patients with chronic renal failure.

Authors:  Iris J Lee; Brendan Hilliard; Abhishek Swami; John C Madara; Swati Rao; Tapan Patel; John P Gaughan; Jean Lee; Crystal A Gadegbeku; Eric T Choi; Philip L Cohen
Journal:  Nephrol Dial Transplant       Date:  2012-08-20       Impact factor: 5.992

3.  Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl in patients with systemic lupus erythematosus and Behçets disease.

Authors:  Tamer A Gheita; Iman H Bassyouni; Rasha H Bassyouni
Journal:  J Clin Immunol       Date:  2012-07-26       Impact factor: 8.317

4.  Increased plasma levels of the soluble Mer tyrosine kinase receptor in systemic lupus erythematosus relate to disease activity and nephritis.

Authors:  Jun Wu; Carl Ekman; Andreas Jönsen; Gunnar Sturfelt; Anders A Bengtsson; Anders Gottsäter; Bengt Lindblad; Elisabet Lindqvist; Tore Saxne; Björn Dahlbäck
Journal:  Arthritis Res Ther       Date:  2011-04-15       Impact factor: 5.156

5.  Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities.

Authors:  Erin D Lew; Jennifer Oh; Patrick G Burrola; Irit Lax; Anna Zagórska; Paqui G Través; Joseph Schlessinger; Greg Lemke
Journal:  Elife       Date:  2014-09-29       Impact factor: 8.140

6.  Circulating growth arrest-specific protein 6 levels are associated with erythropoietin resistance in hemodialysis patients.

Authors:  Miao-Pei Chen; Chien-Wen Chen; Jin-Shuen Chen; Hung-Chung Mao; Chu-Lin Chou
Journal:  Springerplus       Date:  2016-01-13

7.  GAS6 receptor status is associated with dormancy and bone metastatic tumor formation.

Authors:  Russell S Taichman; Lalit R Patel; Rachel Bedenis; Jingcheng Wang; Savannah Weidner; Taibriana Schumann; Kenji Yumoto; Janice E Berry; Yusuke Shiozawa; Kenneth J Pienta
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

8.  Plasma concentrations predict aortic expression of growth-arrest-specific protein 6 in patients undergoing coronary artery bypass grafting.

Authors:  Chien-Hsing Lee; Yi-Shing Shieh; Chien-Sung Tsai; Yi-Jen Hung; Yi-Ting Tsai; Chih-Yuan Lin
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

9.  Circulating levels of soluble MER in lupus reflect M2c activation of monocytes/macrophages, autoantibody specificities and disease activity.

Authors:  Gaetano Zizzo; Justus Guerrieri; Lindsay M Dittman; Joan T Merrill; Philip L Cohen
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

10.  High glucose induces human endothelial dysfunction through an Axl-dependent mechanism.

Authors:  Chien-Hsing Lee; Yi-Shing Shieh; Fone-Ching Hsiao; Feng-Chih Kuo; Chih-Yuan Lin; Chang-Hsun Hsieh; Yi-Jen Hung
Journal:  Cardiovasc Diabetol       Date:  2014-02-26       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.